These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 8578222

  • 1. NSAID-associated upper gastrointestinal damage in patients with rheumatoid arthritis.
    Dijkmans BA, Janssen M, Vandenbroucke JP, Lamers CB.
    Scand J Gastroenterol Suppl; 1995; 212():105-8. PubMed ID: 8578222
    [Abstract] [Full Text] [Related]

  • 2. A gastroscopic study of the predictive value of risk factors for non-steroidal anti-inflammatory drug-associated ulcer disease in rheumatoid arthritis patients.
    Janssen M, Dijkmans BA, Lamers CB, Zwinderman AH, Vandenbroucke JP.
    Br J Rheumatol; 1994 May; 33(5):449-54. PubMed ID: 8173849
    [Abstract] [Full Text] [Related]

  • 3. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis.
    Van Groenendael JH, Markusse HM, Dijkmans BA, Breedveld FC.
    Clin Rheumatol; 1996 Sep; 15(5):450-6. PubMed ID: 8894357
    [Abstract] [Full Text] [Related]

  • 4. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs.
    ten Wolde S, Dijkmans BA, Janssen M, Hermans J, Lamers CB.
    Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962
    [Abstract] [Full Text] [Related]

  • 5. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
    Tang CL, Ye F, Liu W, Pan XL, Qian J, Zhang GX.
    Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
    [Abstract] [Full Text] [Related]

  • 6. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    Chinese Rheumatism Data Center, Chinese Systemic Lupus Erythematosus Treatment and Research Group.
    Zhonghua Nei Ke Za Zhi; 2017 Jan 01; 56(1):81-85. PubMed ID: 28056333
    [Abstract] [Full Text] [Related]

  • 7. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer.
    Voutilainen M, Sokka T, Juhola M, Farkkilä M, Hannonen P.
    Scand J Gastroenterol; 1998 Aug 01; 33(8):811-6. PubMed ID: 9754727
    [Abstract] [Full Text] [Related]

  • 8. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
    Musumba C, Jorgensen A, Sutton L, Van Eker D, Moorcroft J, Hopkins M, Pritchard DM, Pirmohamed M.
    Aliment Pharmacol Ther; 2012 Jul 01; 36(1):48-56. PubMed ID: 22554233
    [Abstract] [Full Text] [Related]

  • 9. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P.
    Scand J Gastroenterol; 2001 Aug 01; 36(8):817-21. PubMed ID: 11495076
    [Abstract] [Full Text] [Related]

  • 10. Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers.
    Taha AS, Dahill S, Morran C, Hudson N, Hawkey CJ, Lee FD, Sturrock RD, Russell RI.
    Gastroenterology; 1999 Feb 01; 116(2):254-8. PubMed ID: 9922304
    [Abstract] [Full Text] [Related]

  • 11. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
    Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS.
    JAMA; 2000 Sep 13; 284(10):1247-55. PubMed ID: 10979111
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
    Simon LS, Weaver AL, Graham DY, Kivitz AJ, Lipsky PE, Hubbard RC, Isakson PC, Verburg KM, Yu SS, Zhao WW, Geis GS.
    JAMA; 1999 Nov 24; 282(20):1921-8. PubMed ID: 10580457
    [Abstract] [Full Text] [Related]

  • 13. Incidence of clinically manifest ulcers and their complications in patients with rheumatoid arthritis.
    Steen KS, Lems WF, Aertsen J, Bezemer D, Dijkmans BA.
    Ann Rheum Dis; 2001 May 24; 60(5):443-7. PubMed ID: 11302864
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
    Cherian PT, Cherian S, Singh P.
    Gastrointest Endosc; 2007 Sep 24; 66(3):491-7. PubMed ID: 17640640
    [Abstract] [Full Text] [Related]

  • 15. Helicobacter pylori infection, ABO blood group, and effect of misoprostol on gastroduodenal mucosa in NSAID-treated patients with rheumatoid arthritis.
    Henriksson K, Uribe A, Sandstedt B, Nord CE.
    Dig Dis Sci; 1993 Sep 24; 38(9):1688-96. PubMed ID: 8359082
    [Abstract] [Full Text] [Related]

  • 16. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment.
    Hawkey CJ.
    Scand J Gastroenterol Suppl; 1996 Sep 24; 220():124-7. PubMed ID: 8898449
    [Abstract] [Full Text] [Related]

  • 17. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication].
    Ballesteros-Amozurrutia MA.
    Rev Gastroenterol Mex; 2000 Sep 24; 65(4 Suppl 2):41-9. PubMed ID: 11464621
    [Abstract] [Full Text] [Related]

  • 18. Serum values of pepsinogens and antibodies to Helicobacter pylori in relation to a history of peptic ulcer disease and NSAID use.
    Janssen M, Dijkmans BA, Vandenbroucke JP, Biemond I, van Duyn W, Zwinderman AH, Lamers CB.
    Scand J Rheumatol; 1995 Sep 24; 24(4):204-8. PubMed ID: 7481582
    [Abstract] [Full Text] [Related]

  • 19. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR.
    Gastroenterology; 2007 Sep 24; 133(3):790-8. PubMed ID: 17854591
    [Abstract] [Full Text] [Related]

  • 20. NSAID-induced gastric mucosal damage.
    Semble EL, Wu WC.
    Am Fam Physician; 1987 Jun 24; 35(6):101-8. PubMed ID: 3332745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.